Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Case Reports in Dermatology|October 27, 2021
Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent PatientSineida Berbert Ferreira, Rachel Berbert Ferreira, Afonso Cesar Neves Neto, et al.Annals of the Rheumatic Diseases|March 23, 2018
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trialJoan T Merrill, William R Shanahan, Morton Scheinberg, et al.Current Rheumatology Reports|June 18, 2017
Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the ClinicianRobert Moots, Valderilio Azevedo, Javier L Coindreau, et al.Mabs|August 30, 2018
Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin AmericaMorton Scheinberg, Carlos Pineda, Gilberto Castañeda-Hernández, et al.Drug Design, Development and Therapy|September 21, 2018
Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptomsMorton Scheinberg, Henrique Pott Júnior, Eduardo de Almeida Macêdo, et al.Annals of the New York Academy of Sciences|September 18, 2009
Alterations in cytokine profile and dendritic cells subsets in peripheral blood of rheumatoid arthritis patients before and after biologic therapyLuciana Marti, Ricardo Golmia, Andrea Pimentel Fonseca Golmia, et al.Clinical Rheumatology|February 18, 2017
Recovery of nail dystrophy potential new therapeutic indication of tofacitinibJose A Jaller, Juan J Jaller, Antonio M Jaller, et al.Expert Review of Clinical Pharmacology|July 4, 2019
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosisMorie A Gertz, Morton Scheinberg, Márcia Waddington-Cruz, et al.Clinical Rheumatology|April 24, 2016
Belimumab for the treatment of corticosteroid-dependent systemic lupus erythematosus: from clinical trials to real-life experience after 1 year of use in 48 Brazilian patientsMorton Scheinberg, Flavio Fernando Nogueira de Melo, Adrian Nogueira Bueno, et al.Lupus|July 13, 2021
The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendationsEvandro Mendes Klumb, Morton Scheinberg, Viviane Angelina de Souza, et al.Pageof 4